Healthcare -
Biotechnology - NASDAQ - US
$ 13.71
-5.46 %
$ 557 M
Market Cap
-2.75
P/E
KROS - REVENUE
Revenue KROS - Keros Therapeutics, Inc.
3.55 M
LAST VALUE
0.00%
2 YEAR CAGR
-18.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR